Related Experiment Video
Updated: May 12, 2026
10:11
Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
B7-H4's role "beyond the tumor"
Ning Yu1, Xiaomei Li, Songguo Zheng
1Department of Rheumatology and Immunology, Affiliated Anhui Provincial Hospital, Anhui Medical University, 17 Lujiang Road, Hefei, Anhui 230001, People's Republic of China.
Inflammation
|April 23, 2013
Summary
B7-H4, an immune-suppressing molecule, plays a role in cancer and autoimmune diseases. Targeting B7-H4 offers potential therapeutic benefits for various conditions beyond tumors.
Area of Science:
- Immunology
- Molecular Biology
- Pathology
Background:
- B7-H4 is a B7 family ligand with immune-suppressive functions.
- Its role is established in cancer and allograft rejection, but less understood in other diseases.
- B7-H4 engagement inhibits immune cell proliferation and induces apoptosis via the Fas/FasL pathway.
Purpose of the Study:
- To review recent advances in B7-H4 biology outside of tumor contexts.
- To explore the therapeutic potential of targeting B7-H4 in various diseases.
Main Methods:
- Literature review of B7-H4 research.
- Analysis of B7-H4's molecular mechanisms and disease associations.
Main Results:
- B7-H4's suppressive immune functions are relevant in autoimmune diseases and allograft rejection.
- Targeting B7-H4 presents therapeutic opportunities for non-tumorigenic conditions.
Conclusions:
- B7-H4 is a significant factor in immune regulation across multiple disease types.
- Targeting B7-H4 and its pathways holds promise for novel therapeutic strategies.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.